NCT04715906

Brief Summary

The purpose of this research study is to collect information to better understand caregiver responses to COVID-19 stress and to help caregivers of children with Autism Spectrum Disorder (ASD) cope with these stressors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 22, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2022

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 16, 2022

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

11 months

First QC Date

December 29, 2020

Last Update Submit

April 26, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Anxiety levels as measured by GAD-7

    Parent Psychopathology levels will be reported as the change in the Generalized Anxiety Disorder 7-item (GAD-7) scores. GAD-7 is a 7-item measure assessing the presence and severity of symptoms of anxiety. The Scale has a total score ranging from 0 to 21 with the higher scores indicating greater anxiety.

    Baseline, 6 Weeks

  • Change in depressive symptoms as measured by the PHQ

    Parent Psychopathology levels will be reported as the change in the Patient Health Questionnaire (PHQ) scores. PHQ is a 9-item measure assessing the severity of depressive symptoms. It has a total score ranging from 0 to 27 with the higher scores indicating greater depressive symptoms.

    Baseline, 6 Weeks

Secondary Outcomes (3)

  • Change in parenting beliefs as measured by the PSOC Scale

    Baseline, 6 Weeks

  • Change in Hope as measured by the State Hope Scale

    Baseline, 6 Weeks

  • Acceptability of Intervention as measured by the Program Feedback Scale

    6 Weeks

Study Arms (1)

UP-Caregiver Group

EXPERIMENTAL

Unified Protocol (UP) Caregiver Group will receive the UP for Transdiagnostic Treatment of Emotional Disorders for Caregivers intervention via telehealth using Zoom for a minimum of 4 up to 8 sessions ideally within 8 weeks.

Behavioral: UP-Caregiver

Interventions

UP-CaregiverBEHAVIORAL

The Unified Protocol (UP) is a telehealth group session using Zoom with each session lasting approximately 60-90 minutes. The sessions will focus on a variety of Cognitive Behavior Therapy techniques. These sessions may include teaching coping skills, goal setting, parent-child problem solving and communication, and motivation during this pandemic.

UP-Caregiver Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be willing to consent to participate via RedCap
  • Indicate a mild or greater elevation on screening measures of anxiety and/or depression

You may not qualify if:

  • Lives in Florida
  • Has a child between the ages of 4-13 years who has been diagnosed with ASD
  • Speaks either English or Spanish primarily
  • Has technical capacity to participate in Zoom sessions on a mobile device or preferably a computer
  • Severe mental illness (e.g., bipolar disorder, schizophrenia, an intellectual disability, psychosis, alcohol use disorder, substance use disorder) or hospitalization for mental health concerns or suicide attempt. Parents may receive concurrent psychiatric or psychological intervention services but may be excluded if the severity of current mental illness is such that outpatient, weekly group treatment would be considered inappropriate.
  • Parents who report any prior arrest for child endangerment, child abuse or child neglect may also be excluded.
  • Parents who have Moderate or greater risk of suicidal ideation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Jill Ehrenreich-May, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Assistant Chair for Academic Affairs and Research

Study Record Dates

First Submitted

December 29, 2020

First Posted

January 20, 2021

Study Start

February 22, 2021

Primary Completion

January 26, 2022

Study Completion

February 16, 2022

Last Updated

April 27, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations